Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma
Crossref DOI link: https://doi.org/10.1007/s00280-015-2776-x
Published Online: 2015-05-26
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Burke, John M.
van der Jagt, Richard H. C.
Flinn, Ian W.
Craig, Michael D.
Chen, Ling
Morganroth, Joel
Munteanu, Mihaela C.
MacDonald, David A.
Text and Data Mining valid from 2015-05-26
Version of Record valid from 2015-05-26
Article History
Received: 7 April 2015
Accepted: 8 May 2015
First Online: 26 May 2015